Indoco Remedies Q4 net profit down 14 pc at Rs 18 crore
Drug firm Indoco Remedies reported a 14.36 per cent decline in standalone net profit at Rs 17.94 crore for the March quarter.
The company had posted a net profit of Rs 20.95 crore during the January-March quarter of previous fiscal, Indoco Remedies said in a BSE filing.
Total income from operations during the quarter under review stood at Rs 276.94 crore, as against Rs 265.22 crore in the year ago period, down 4.41 per cent.
For the entire fiscal, the company reported a net profit of Rs 77.45 crore compared to Rs 82.29 crore in the 2015-16 fiscal.
Shares of Indoco Remedies were trading at Rs 191, down 0.49 per cent on BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd